Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 12, 2024 | Back issues
Courthouse News Service Courthouse News Service

Widow Says Husband Bled To Death|In Clinical Trial Of Anticoagulant Drug

JACKSONVILLE, FLA. (CN) - A widow says her husband died of internal bleeding while participating in a clinical trial of a new anti-coagulant drug made by Boehringer Ingelheim Pharmaceutical. Oliver Hone, 72, died of gastrointestinal hemorrhaging three weeks into the trial of Dabigatran Etexilate, his widow says in Federal Court.

Linda Hone says Boehringer "either conducted or is still conducting" the clinical trial, throughout the world and in all 50 states. She says the company has failed to warn participants that should an "adverse bleeding event" like Hone's occur, there is no known anecdote.

She demands damages for wrongful death. She is represented by Earl Hooten and Michael Seelie.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.